UroGen Pharma Ltd. (URGN): Margin dodolan resik

Tandha merek urogen.com (URGN)

Operating net profit margins demonstrate the status of UroGen Pharma Ltd. (URGN) as an expert in targeted therapy for urological tumors via hydrogel systems. The brand's authority among oncologists is bolstered by the creation of unique drug formulations for comfortable treatment. Scaling specialized gels across clinics optimizes costs, while the metric remains at -26.30, confirming current profit management efficiency.

Rentabilitas dodolan resik urogen.com (URGN): kanggo periode 04.07.2022 - 20.11.2026

Rincian analitis perusahaan UroGen (URGN)

- rega saham lan prakiraan rega para ahli:
Ringkesan analitik perusahaan:urogen.com - URGN
Produk asil prodhuksi UroGen Pharma Ltd

The specific nature of UroGen Pharma Ltd. (URGN) as a uro-oncology research business with a minimal manufacturing footprint determines the dynamics reflected in the current net profit margin. This ratio is calculated as the relationship between the final financial result and total revenue, measuring the profit share of each unit of income to assess cost management efficiency and the overall fundamental stability of the company.

Analisis pesaing

ONC: Margin dodolan resik|Margin resik Halozyme Inc. (HALO)|Margin resik RevMed|Rentabilitas dodolan resik AAPG (Ascentage Pharma Group)|Margin dodolan resik CGON|Margin dodolan resik Bicara Therapeutics (BCAX)|Margin dodolan resik PSNL (personalis.com)|Tingkat bathi resik ERAS|DCTH: Rentabilitas dodolan miturut bathi resik|YmAbs - Rentabilitas resik perusahaan|aurabiosciences.com (AURA) - Margin resik|Candel Therapeutics Inc. - Tingkat bathi resik|Margin resik Accuray Inc.|Margin resik SELLAS Life Sciences Group SLS|Margin dodolan resik ACTU|CTOR - Margin resik|Margin dodolan resik HURA (TuHURA Biosciences, Inc.)|Tingkat bathi resik TARA|FATE: Rentabilitas dodolan miturut bathi resik|WHWK (aadibio.com) - Rentabilitas dodolan resik|TCRX (TScan Therapeutics, Inc.) - Rentabilitas dodolan miturut bathi resik|Margin resik Champions Oncology Corp (CSBR)|XBIT (XBiotech Inc.) - Margin dodolan resik|CVM (CEL-SCI Corporation) - Rentabilitas resik perusahaan|Margin dodolan resik OSTX|Margin dodolan resik Radiopharm Theranostics Ltd (RADX)|Margin dodolan resik ARTV (Artiva Biotherapeutics)|Margin dodolan resik Adlai Nortye Ltd. ANL|Veru Inc - Margin dodolan resik|Margin dodolan perusahaan Tempest Therapeutics TPST|XLO: Margin dodolan resik|Enochian BioSciences (RENB) - Margin dodolan resik|Rentabilitas dodolan miturut bathi resik MURA|Kairos Pharma Ltd - Margin bathi resik|Margin dodolan resik OKUR|CytoMed Therapeutics Limited (GDTC) - Tingkat bathi miturut bathi resik|Margin dodolan resik CRIS (Curis, Inc.)|APLM: Rentabilitas dodolan resik|Tharimmune Corporation - Margin dodolan resik|ADVB: Margin resik|GNPX: Margin dodolan resik|CLDI (Calidi Biotherapeutics Inc.) - Margin resik|Margin resik Sunshine Biopharma, Inc.|Margin dodolan resik xeneticbio.com|Margin resik Salarius (SLRX)|Rentabilitas dodolan miturut bathi resik Purple Biotech PPBT|Margin resik American Oncology Network, Inc. AONC|BeiGene, Ltd. (BGNE) - Margin resik|Checkpoint Therapeutics Inc. - Margin dodolan resik|Tingkat bathi resik ELEV (Elevation Oncology)|ICAD (iCAD Corp) - Rentabilitas dodolan miturut bathi resik|Ikena Oncology, Inc. - Tingkat bathi resik|Rentabilitas dodolan miturut bathi resik NTBL|VIRX: Tingkat bathi resik|Margin resik MorphoSys Corporation (MOR)|NAYA - Margin resik|Margin dodolan resik AAPGV (Ascentage)